Panitumumab (89Zr-labeled)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Panitumumab (89Zr-labeled), covering 2025-12-19 to 2025-12-19. Get the full timeline:
Most recent: Clinical Trial Update: (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma [Phase 1]